FDA Expedites ANDA Postapproval Manufacturing Changes
Acceleration Necessary Due To COVID-19 Impacts
Generic drugs program has approved almost 300 manufacturing changes to help shore up the supply chain, with some prior approval supplements being downgraded to ‘changes being effected’ supplements, FDA officials said at GDUFA III kick-off meeting.
